Clinical Sciences/Health Conditions
Haibo Liu, MD
physician
Chongqing Liangping People's Hospital
Chongqing, Chongqing, China (People's Republic)
This study aimed to evaluate the efficacy of autologous platelet-rich plasma combined with ultrasound-guided suprascapular nerve pulsed radiofrequency in the treatment of adhesive capsulitis.
Design:
Patients with adhesive capsulitis who were treated at the Pain Department of Liangping District People’s Hospital of Chongqing, from January 2023 to December 2024 were retrospectively screened. Patients in the control group(n=54) received pulsed radiofrequency treatment of the suprascapular nerve alone, whereas those in the intervention group(n=47) received autologous platelet-rich plasma in addition to suprascapular nerve pulsed radiofrequency under ultrasound guidance.
Results:
In the comparison of VAS scores, the intervention group showed significantly lower pain scores than the control group at week 1 (4.95 ± 0.91 vs 5.48 ± 1.08), week 2 (4.35 ± 0.98 vs 4.97 ± 1.11), week 3(3.91 ± 0.94 vs 4.46 ± 0.83), and week 4 (3.22 ± 0.88 vs 3.82 ± 1.04) (all P<0.05). However, no significant difference was observed at week 8(2.41 ± 0.77 vs 2.59 ± 0.84) (P>0.05). Regarding CSS, the intervention group demonstrated superior functional improvement compared with the control group at week 1(51.36 ± 6.85 vs 47.20 ± 7.24), week 2(58.04 ± 6.18 vs 53.45 ± 5.07), week 3(64.12 ± 7.02 vs 59.35 ± 7.85), and week 4(69.45 ± 6.70 vs 64.80 ± 6.21) (all P< 0.05). No significant difference was found at week 8(77.18 ± 4.39 vs 75.63 ± 5.87) (P>0.05).
Conclusion:
The combination of autologous platelet-rich plasma with ultrasound-guided suprascapular nerve pulsed radiofrequency was more effective than pulsed radiofrequency alone within the first 8 weeks of treatment.
